A Study of Encapsulated Cell Technology (ECT) Implant for Participants With Early Stage Retinitis Pigmentosa
Estado: Terminado |
Categoría: Retinosis pigmentaria |
Resultado: No tiene resultados
RETINOSIS PIGMENTARIA
Drug: NT-501
Retina-Vitreous Associates Medical Group, Beverly Hills, California, United States
University of Califoria, Davis, Sacramento, California, United States
University of California, San Francisco, San Francisco, California, United States
Bascom Palmer Eye Insitute, Miami, Florida, United States
Ophthalmic Consultants of Boston, Boston, Massachusetts, United States
Kellogg Eye Center, Ann Arbor, Michigan, United States
University of Minnesota, Minneapolis, Minnesota, United States
NY University Medical Center, New York, New York, United States
Casey Eye Institue, Portland, Oregon, United States
The Hamilton Eye Institute, Memphis, Tennessee, United States
Retina Foundation of Southwest, Dallas, Texas, United States
University of Utah, Salt Lake City, Utah, United States
Ver informe